Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business – Read more
Please find below further information on availability in different regions and links to relevant information and forms. If you are a patient, you can speak to your doctor for more information on HRD testing.
MyChoice CDx Plus is a CE marked device and has been designed to conform to the applicable standards and the general safety and performance requirements of the European Directive 98/79/EC (in vitro Diagnostic Medical Devices). The declaration of conformity is issued under the responsibility of Myriad Genetic Laboratories, Inc.
The technical specifications for MyChoice CDx Plus including the intended use can be found here.
Click on the report to the right to view an example MyChoice CDx Plus result or see the full report here.
Please note that test result reports may look different when ordering from a partner lab.
If there are no labs in your country, you can send a sample to Myriad’s central laboratory in Salt Lake City, USA. Simply order a sample transportation box and follow the instructions for preparing and shipping your sample.
If you need a fillable test request form, you can find this below in different languages.
The technical specifications for MyChoice HRD Plus including the intended use can be found here.
Click on the report to the left to view an example MyChoice HRD Plus result or see the full report here.
To begin using MyChoice HRD Plus Companion Diagnostic Test to guide your ovarian cancer treatment decisions, please order a sample transportation set below.
The technical specifications for MyChoice CDx can be found here.
To begin using MyChoice CDx Companion Diagnostic Test to guide your ovarian cancer treatment decisions please visit our US page.
High-quality sample selection means high-quality patient care.
We understand sample selection cannot always be optimal, but MyChoice can give the results each woman needs with enough tumor content. Ensuring specimens have at least 30% tumor cells in tissue or fluid samples is one of the best ways to ensure MyChoice test success.
Preferably, the tumor specimen should also be treatment-naïve.
For more tips like this and guidance on how to select and prepare a sample for HRD testing, please download our pathologist guide.